Literature DB >> 17541043

The homocysteine hypothesis of depression.

Marshal Folstein1, Timothy Liu, Inga Peter, Jennifer Buell, Jennifer Buel, Lisa Arsenault, Tammy Scott, Wendy W Qiu.   

Abstract

High levels of homocysteine are associated with cerebrovascular disease, monoamine neurotransmitters, and depression of mood. A plausible hypothesis for these associations is that high homocysteine levels cause cerebral vascular disease and neurotransmitter deficiency, which cause depression of mood. The homocysteine depression hypothesis, if true, would mandate inclusions of imaging studies for cerebrovascular disease and measures of homocysteine, folate, and B12 and B6 vitamins in the clinical evaluation of older depressed patients. Longitudinal studies and clinical trials should be designed to challenge the hypothesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17541043     DOI: 10.1176/ajp.2007.164.6.861

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  71 in total

Review 1.  Preventative strategies for early-onset bipolar disorder: towards a clinical staging model.

Authors:  Robert K McNamara; Jayasree J Nandagopal; Stephen M Strakowski; Melissa P DelBello
Journal:  CNS Drugs       Date:  2010-12       Impact factor: 5.749

2.  Serum levels of homocysteine at admission are associated with post-stroke depression in acute ischemic stroke.

Authors:  Yan Li; Li-Li Cao; Lin Liu; Qin-De Qi
Journal:  Neurol Sci       Date:  2017-02-18       Impact factor: 3.307

Review 3.  The impact of vascular burden on late-life depression.

Authors:  Micaela Santos; Enikö Kövari; Patrick R Hof; Gabriel Gold; Constantin Bouras; Panteleimon Giannakopoulos
Journal:  Brain Res Rev       Date:  2009-09-08

Review 4.  The annexin A2 system and vascular homeostasis.

Authors:  Elle C Flood; Katherine A Hajjar
Journal:  Vascul Pharmacol       Date:  2011-03-29       Impact factor: 5.773

Review 5.  The Role of Nutrients in Protecting Mitochondrial Function and Neurotransmitter Signaling: Implications for the Treatment of Depression, PTSD, and Suicidal Behaviors.

Authors:  Jing Du; Ming Zhu; Hongkun Bao; Bai Li; Yilong Dong; Chunjie Xiao; Grace Y Zhang; Ioline Henter; Matthew Rudorfer; Benedetto Vitiello
Journal:  Crit Rev Food Sci Nutr       Date:  2016-11-17       Impact factor: 11.176

6.  Status of vitamins B-12 and B-6 but not of folate, homocysteine, and the methylenetetrahydrofolate reductase C677T polymorphism are associated with impaired cognition and depression in adults.

Authors:  Denish Moorthy; Inga Peter; Tammy M Scott; Laurence D Parnell; Chao-Qiang Lai; Jimmy W Crott; José M Ordovás; Jacob Selhub; John Griffith; Irwin H Rosenberg; Katherine L Tucker; Aron M Troen
Journal:  J Nutr       Date:  2012-06-27       Impact factor: 4.798

7.  The efficacy of vitamins for reducing or preventing depression symptoms in healthy individuals: natural remedy or placebo?

Authors:  Alison America; Leonard S Milling
Journal:  J Behav Med       Date:  2008-04

8.  Association analysis of the COMT/MTHFR genes and geriatric depression: an MRI study of the putamen.

Authors:  Chih-Chuan Pan; Douglas R McQuoid; Warren D Taylor; Martha E Payne; Allison Ashley-Koch; David C Steffens
Journal:  Int J Geriatr Psychiatry       Date:  2009-08       Impact factor: 3.485

9.  High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial.

Authors:  Paul S Aisen; Lon S Schneider; Mary Sano; Ramon Diaz-Arrastia; Christopher H van Dyck; Myron F Weiner; Teodoro Bottiglieri; Shelia Jin; Karen T Stokes; Ronald G Thomas; Leon J Thal
Journal:  JAMA       Date:  2008-10-15       Impact factor: 56.272

10.  Vitamin B12 status in patients of Turkish and Dutch descent with depression: a comparative cross-sectional study.

Authors:  Yener Güzelcan; Peter van Loon
Journal:  Ann Gen Psychiatry       Date:  2009-08-13       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.